Post Type Archives: News

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635) (“PPS”), has officially unveiled a new, state-of-the-art payload-linker development and manufacturing suite at its Riverview, Michigan drug substance facility. This launch is a key element of the company’s broader $90 million investment […]

 Shilpa Medicare Limited, a global integrated pharmaceutical and CDMO company, today announced the signing of a long-term development and commercial manufacturing agreement with NXI Therapeutics AG, Switzerland. Under the terms of agreement, Shilpa group will provide comprehensive CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support. The collaboration spans early development through commercialization, positioning […]

Novo Nordisk today announced data demonstrating that Wegovy® (semaglutide 2.4 mg and 7.2 mg) delivers substantial and consistent weight-loss results for women with obesity across reproductive life stages, from premenopausal years through the menopause transition and beyond1. The menopausal stages are perimenopause (the transition phase), menopause and postmenopause (after menopause). The findings are based on […]

Nanoform Finland Plc the medicine performance‑enhancing company, announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines. Under the agreement, the partner will pay Nanoform a non-refundable initial USD […]

The Cyprus presidency of the EU Council has reached a provisional agreement with the European Parliament on a new regulation that seeks to strengthen the EU’s resiliencein addressing ongoing challenges to security of supply of critical medicines in Europe. The critical medicines act (CMA) aims to tackle shortages of key medicines such as antibiotics, insulin […]

Informa Markets has announced its keynote speaker line-up for CPHI Americas 2026 (June 2–4), bringing together more than 80 industry thought leaders, including senior voices from the U.S. Food and Drug Administration (FDA), to address the most pressing challenges shaping the pharmaceutical industry. Spanning three days, CPHI Americas will gather senior leaders from across the […]

NunaBio, a next-generation DNA manufacturing company, has secured £6.5 million in funding to scale-up its proprietary DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research. The funding will support the ongoing development of NunaBio’s integrated DNA platform, which combines multiple enzymatic technologies with proprietary hardware […]

Today, Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 62.58% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 43,948,027 shares. All Board members standing for re-election were re-elected, each for a further term in office until the completion of the AGM 2027. The following Board members stood for re-election: Jean-Marc Huët, Juan Andres, Eric […]

In its qualitative Q1 2026 business update, Lonza1 reported a strong performance across its CDMO business in line with the expected trajectory for Full-Year 2026. As expected, due to a lower prior year base, campaign timing and product releases, and planned site shutdowns, CER sales growth and CORE EBITDA margin will be notably stronger in […]

Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), and Bristol Myers Squibb (NYSE: BMY), a global pharmaceutical company dedicated to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases, today announced an exclusive single-target licensing agreement. Under the terms of this agreement, BMS will gain exclusive access to […]